Founded
31 Dec 2000
VCID: 346796
Profile
Corporate information
Registration country
Registration country
Investment activity status
Active investor
Company type
Discovers and commercializes novel antibody based drugs and drug targets for the major mental and neuro-degenerative diseasesFunding
Funding rounds
(1 Aug 2003)
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
MPM Capital | United States | Initial investment. Round participant. | |
|
Prospect Venture Partners | Venture capital firm | United States | Initial investment. Round participant. |
|
Schroder Ventures Life Sciences Inc | United States | Initial investment. Round participant. | |
|
Essex Woodlands Health Ventures Inc | United States | Follow-on investment. Round participant. | |
|
|
Technology Partners. | Venture capital firm | United States | Follow-on investment. Round participant. |
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
|
Essex Woodlands Health Ventures Inc | United States | Initial investment. Round participant. | |
|
|
Technology Partners. | Venture capital firm | United States | Initial investment. Round participant. |
Cap Table
Current and past shareholders
| Investor | Contacts | Round | |
|---|---|---|---|
|
|
Essex Woodlands Health Ventures Inc |
+1 (281) 364-1555 |
Series A Series B |
|
|
MPM Capital |
+1 (650) 553-3300 |
Series B |
|
|
Prospect Venture Partners Venture capital firm |
+1 (650) 327-8800 |
Series B |
|
|
Schroder Ventures Life Sciences Inc |
Series B | |
|
SV Health Investors LLP |
N/A (exited) | |
|
|
Technology Partners. Venture capital firm |
+1 (650) 289-9000 |
Series A Series B |